Search for Clinical Trial Results
Neurofibromatosis Type 1 - 26 Studies Found
Status | Study |
Completed |
Study Name: Natural History and Biology of Skin Neurofibromas in Neurofibromatosis Type 1 Condition:
Date: 2006-04-11 |
Completed |
Study Name: MicroRNAs in Patients With Neurofibromatosis Type 1 Condition:
Date: 2012-05-08 |
Completed |
Study Name: Neurofibromatosis Type 1 (NF1) and Tibial Dysplasia Condition:
Date: 2006-03-14 |
Terminated |
Study Name: Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1) Condition: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1 Date: 2011-05-27 Interventions: Drug: Everolimus (RAD001) oral daily dosing of tablet starting with 2.5 mg |
Enrolling by invitation |
Study Name: Analysis of Plasma for Diagnosis and Follow-up of Neurofibromatosis Type 1 Condition: Neurofibromatosis 1 Date: 2016-01-15 Interventions: Other: Blood sample 10 mL venous blood sample for analysis of plasma |
RECRUITING |
Study Name: US Selumetinib Registry Condition: Neurofibromatosis Type 1 Date: 2024-05-19 |